Pathway analysis also confirmed that PI3K/Akt signaling was enriched in IDH-wt grade II/III glioma samples and apoptotic processes were enriched in GBM samples (Supplemental Fig. 2d). The gene discussed is AKT1; the disease is central nervous system cancer.